GMU to offer UAE's first formal longevity medicine training

Mangaluru

Thumbay Group has signed an MoU with Switzerland's Geneva College of Longevity Science to introduce the UAE's first structured programmes in longevity medicine, healthy ageing, preventive healthcare and precision health at Gulf Medical University. The collaboration will be implemented through the newly established Thumbay Institute of Longevity Medicine, making GMU the first private medical university in the UAE to offer formal academic education in the emerging field.

Six professional certificate programmes will be launched in clinical longevity medicine, longevity physiotherapy, longevity nutrition, longevity fitness, peptide medicine and artificial intelligence in healthcare. Each programme will be offered in a hybrid format over three months, with an initial intake of around 100 participants. The courses are aimed at physicians, pharmacists, nurses, physiotherapists, nutritionists, fitness professionals and allied healthcare practitioners.

The curriculum has been developed by GCLS and will be delivered with support from international faculty and regional clinical experts, while leveraging GMU's academic infrastructure and Thumbay Healthcare's clinical network. Thumbay Group said the initiative aligns with the UAE's ambition to become a global centre for advanced healthcare, preventive medicine and medical innovation, while strengthening the Gulf region's capabilities in longevity science. Dr Thumbay Moideen, Founder President of Thumbay Group, said the partnership would bring Swiss academic standards to the UAE and equip healthcare professionals with specialised skills needed for the evolving healthcare landscape.

Dr Dominik Thor, President of GCLS, said longevity medicine was rapidly becoming an integral part of modern healthcare and required robust academic standards and specialised training. The collaboration is expected to expand beyond education into joint conferences, workshops and research initiatives in the coming years. According to GCLS's 2026 Global Longevity Physician Survey, 99 per cent of longevity physicians reported rising patient demand, while 83 per cent believe healthcare will increasingly shift towards prevention.